Lin SH - Search Results

1

An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses.

Meraz IM, Majidi M, Meng F, Shao R, Ha MJ, Neri S, Fang B, Lin SH, Tinkey PT, Shpall EJ, Morris J, Roth JA. Meraz IM, et al. Among authors: lin sh. Cancer Immunol Res. 2019 Aug;7(8):1267-1279. doi: 10.1158/2326-6066.CIR-18-0874. Epub 2019 Jun 11. Cancer Immunol Res. 2019. PMID: 31186248 Free PMC article.

2

Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy.

Pataer A, Kalhor N, Correa AM, Raso MG, Erasmus JJ, Kim ES, Behrens C, Lee JJ, Roth JA, Stewart DJ, Vaporciyan AA, Wistuba II, Swisher SG; University of Texas M. D. Anderson Lung Cancer Collaborative Research Group. Pataer A, et al. J Thorac Oncol. 2012 May;7(5):825-32. doi: 10.1097/JTO.0b013e318247504a. J Thorac Oncol. 2012. PMID: 22481232 Free PMC article.

3

The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapy.

Amini A, Correa AM, Komaki R, Chang JY, Tsao AS, Roth JA, Swisher SG, Rice DC, Vaporciyan AA, Lin SH. Amini A, et al. Among authors: lin sh. Ann Thorac Surg. 2012 Sep;94(3):914-20. doi: 10.1016/j.athoracsur.2012.04.088. Epub 2012 Jul 21. Ann Thorac Surg. 2012. PMID: 22819472 Free PMC article.

4

CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma.

Saintigny P, Massarelli E, Lin S, Ahn YH, Chen Y, Goswami S, Erez B, O'Reilly MS, Liu D, Lee JJ, Zhang L, Ping Y, Behrens C, Solis Soto LM, Heymach JV, Kim ES, Herbst RS, Lippman SM, Wistuba II, Hong WK, Kurie JM, Koo JS. Saintigny P, et al. Cancer Res. 2013 Jan 15;73(2):571-82. doi: 10.1158/0008-5472.CAN-12-0263. Epub 2012 Nov 30. Cancer Res. 2013. PMID: 23204236 Free PMC article.

5

Predictors for locoregional recurrence for clinical stage III-N2 non-small cell lung cancer with nodal downstaging after induction chemotherapy and surgery.

Amini A, Lou F, Correa AM, Baldassarre R, Rimner A, Huang J, Roth JA, Swisher SG, Vaporciyan AA, Lin SH. Amini A, et al. Among authors: lin sh. Ann Surg Oncol. 2013 Jun;20(6):1934-40. doi: 10.1245/s10434-012-2800-x. Epub 2012 Dec 20. Ann Surg Oncol. 2013. PMID: 23263700 Free PMC article.

6

Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint.

Hellmann MD, Chaft JE, William WN Jr, Rusch V, Pisters KM, Kalhor N, Pataer A, Travis WD, Swisher SG, Kris MG; University of Texas MD Anderson Lung Cancer Collaborative Group. Hellmann MD, et al. Lancet Oncol. 2014 Jan;15(1):e42-50. doi: 10.1016/S1470-2045(13)70334-6. Lancet Oncol. 2014. PMID: 24384493 Free PMC article. Review.

7

Therapy-resistant cancer stem cells have differing sensitivity to photon versus proton beam radiation.

Zhang X, Lin SH, Fang B, Gillin M, Mohan R, Chang JY. Zhang X, et al. Among authors: lin sh. J Thorac Oncol. 2013 Dec;8(12):1484-91. doi: 10.1097/JTO.0b013e3182a5fdcb. J Thorac Oncol. 2013. PMID: 24389430 Free PMC article.

8

Hsp90 Inhibitor Ganetespib Sensitizes Non-Small Cell Lung Cancer to Radiation but Has Variable Effects with Chemoradiation.

Wang Y, Liu H, Diao L, Potter A, Zhang J, Qiao Y, Wang J, Proia DA, Tailor R, Komaki R, Lin SH. Wang Y, et al. Among authors: lin sh. Clin Cancer Res. 2016 Dec 1;22(23):5876-5886. doi: 10.1158/1078-0432.CCR-15-2190. Epub 2016 Jun 28. Clin Cancer Res. 2016. PMID: 27354472 Free PMC article.

9

RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer.

Wang Y, Gudikote J, Giri U, Yan J, Deng W, Ye R, Jiang W, Li N, Hobbs BP, Wang J, Swisher SG, Fujimoto J, Wistuba II, Komaki R, Heymach JV, Lin SH. Wang Y, et al. Among authors: lin sh. Clin Cancer Res. 2018 Jan 15;24(2):341-350. doi: 10.1158/1078-0432.CCR-17-1455. Epub 2017 Oct 13. Clin Cancer Res. 2018. PMID: 29030353

10

Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer.

Barua S, Fang P, Sharma A, Fujimoto J, Wistuba I, Rao AUK, Lin SH. Barua S, et al. Among authors: lin sh. Lung Cancer. 2018 Mar;117:73-79. doi: 10.1016/j.lungcan.2018.01.022. Epub 2018 Feb 4. Lung Cancer. 2018. PMID: 29409671 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,639 results

Search Page